WEST VALLEY CITY, Utah, May 6, 2024 /PRNewswire/ -- Scientia Vascular, a leader in neurovascular innovation, is thrilled to announce the FDA clearance of two uniquely engineered catheters: the Plato 17—a DMSO-compatible microcatheter—and the Socrates 38, an aspiration catheter engineered for ischemic stroke.

犹他州西谷城，2024年5月6日/新闻通讯社/--神经血管创新的领导者Scientia Vascular激动地宣布FDA批准了两种独特的工程导管：Plato 17-a DMSO兼容微导管和苏格拉底38，一种专为缺血性中风设计的抽吸导管。

This marks a significant milestone for Scientia's ascent in the neurovascular market, showcasing the company's commitment to pioneering medical advancements..

这标志着Scientia在神经血管市场上升的一个重要里程碑，展示了该公司对开创医学进步的承诺。。

The introduction of Plato® 17 microcatheter and Socrates® 38 aspiration catheter epitomizes Scientia's ethos of continuous innovation. Renowned for disrupting the industry with microfabricated guidewires, Scientia has applied the same groundbreaking technologies, design principles, and precision machinery to revolutionize catheter manufacturing.

Plato®17微导管和Socrates®38抽吸导管的引入体现了科学不断创新的精神。Scientia以微制造导丝颠覆行业而闻名，它应用了相同的开创性技术，设计原理和精密机械来彻底改变导管制造。

This distinct approach exemplifies the company's dedication to pushing the boundaries of medical technology..

这种独特的方法体现了该公司致力于推动医疗技术的界限。。

Socrates 38: Pioneering Aspiration Catheter in Limited Market Release

苏格拉底38：在有限的市场投放中开创性的抽吸导管

Currently in the midst of a limited market release, the Socrates 38 aspiration catheter is gathering valuable feedback and clinical insights. This phase is crucial for executing the final stages of the strategic launch and bringing better, more advanced options to physicians treating stroke.

目前，在有限的市场发布过程中，苏格拉底38抽吸导管正在收集有价值的反馈和临床见解。这一阶段对于执行战略启动的最后阶段以及为治疗中风的医生带来更好，更先进的选择至关重要。

Plato 17: A New Era in Microcatheter Technology

柏拉图17：微导管技术的新时代

The Plato 17 microcatheter, compatible with DMSO, represents a leap forward in catheter design, offering physicians control and stability for a multitude of neurovascular applications. This innovation is a testament to Scientia's ability to transfer groundbreaking technology from one product line to another, enhancing clinical value in patient treatment..

与DMSO兼容的Plato 17微导管代表了导管设计的飞跃，为医生提供了多种神经血管应用的控制和稳定性。这项创新证明了Scientia能够将开创性的技术从一个产品线转移到另一个产品线，从而提高了患者治疗的临床价值。。

A Message from the CEO

CEO致辞

'Our FDA clearance is a significant milestone for Scientia Vascular. By applying proven microfabrication technology to catheters and designing our access and treatment devices for efficiency when used together, we're providing physicians the next generation of neurovascular access tools.' says John Lippert, CEO of Scientia Vascular.

“我们的FDA批准是Scientia Vascular的一个重要里程碑。通过将成熟的微制造技术应用于导管，并设计我们的接入和治疗设备，使其在一起使用时效率更高，我们为医生提供了下一代神经血管接入工具。”Scientia Vascular首席执行官约翰·利珀特（JohnLippert）表示。

'I am immensely grateful to our dedicated teams whose tireless efforts have made this FDA clearance milestone possible. Their commitment to excellence and innovation continues to drive our patient mission forward.'.

“我非常感谢我们敬业的团队，他们的不懈努力使这一FDA批准里程碑成为可能。他们对卓越和创新的承诺继续推动我们的患者使命向前发展。”。

Anticipation for Full Market Release

预计全面上市

'We've seen what microfabrication can do in products like our Aristotle® 24 and Colossus wires in changing the standard of care for patient treatment in stroke, so it's rewarding to see the excitement and buzz surrounding microfabricated technology in catheters with our physician community,' shares Paul Fischer, Chief Commercial Officer for Scientia Vascular.

Scientia Vascular首席商务官保罗·菲舍尔（Paul Fischer）分享道：“我们已经看到了微制造技术在亚里士多德®24和巨像电线等产品中可以改变中风患者治疗的护理标准，因此，与我们的医生社区一起看到导管中微制造技术的兴奋和嗡嗡声是值得的。”。

'We are eager to see how these advanced technologies will enhance patient care and offer new possibilities for physicians treating a variety of neurovascular disease states.'.

“我们渴望看到这些先进技术如何增强患者护理，并为医生治疗各种神经血管疾病状态提供新的可能性。”。

About Scientia Vascular

关于Scientia Vascular

Scientia Vascular is committed to enhancing patient care through innovative medical devices. With a focus on neurovascular advancements, Scientia Vascular remains at the forefront of technological breakthroughs in the medical field.

Scientia Vascular致力于通过创新医疗设备加强患者护理。由于专注于神经血管的进步，Scientia Vascular仍然处于医学领域技术突破的前沿。

For more information, contact:

有关更多信息，请联系：

Larry Myres

拉里·迈尔斯

Chief Operations Officer

首席运营官

Scientia Vascular, Inc.

Scientia Vascular公司。

lmyres@scientiavascular.com

lmyres@scientiavascular.com

760.889.4649

760.889.4649

View original content to download multimedia:https://www.prnewswire.com/news-releases/scientia-vascular-announces-fda-approvals-for-new-line-of-microfabricated-neurovascular-catheters-302135089.html

查看原始内容以下载多媒体：https://www.prnewswire.com/news-releases/scientia-vascular-announces-fda-approvals-for-new-line-of-microfabricated-neurovascular-catheters-302135089.html

SOURCE Scientia Vascular

血管源科学